<DOC>
	<DOCNO>NCT01687491</DOCNO>
	<brief_summary>This study clinical trial monocentric , open , randomized ENOXA 速 versus LOVENOX 速 , conduct two parallel group patient admit emergency acute coronary syndrome .</brief_summary>
	<brief_title>Comparison Anti-Xa Activity ENOXA 速 Versus LOVENOX 速 Acute Coronary Syndrome</brief_title>
	<detailed_description>The patient include study acute coronary Syndrome admit emergency room receive treatment enoxaparin . Low molecular weight heparin ( LMWH ) treatment indication usually spread week . The experience study intend focus first injection administer select patient . Two assay carry , include assessment anti-Xa activity initially injection enoxaparin , 4 hour administration first syringe . Clinical monitoring intrahospital date hospitalization patient include emergency exit ( transfer another service , return home ) Tolerance assessment ( clinical biological ) perform follow-up .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Enoxaparin</mesh_term>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<mesh_term>Dalteparin</mesh_term>
	<criteria>Male female age 20 year acute coronary syndrome Admission emergency department Patient participate another study Pregnant lactate childbearing potential use medically accept method contraception Taking anticoagulant last three month Patient know haemostatic disorder Contraindication absolute / relative use enoxaparin Nobody wish participate study ability understand objective</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Enoxaparin</keyword>
	<keyword>Acute Coronary Syndrome</keyword>
	<keyword>Factor X</keyword>
</DOC>